Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Apr 2;99(7):4703-7.
doi: 10.1073/pnas.052587399.

Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI

Affiliations

Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI

Rachael I Scahill et al. Proc Natl Acad Sci U S A. .

Abstract

Alzheimer's disease (AD) is characterized by progressive cerebral atrophy, which may be assessed by using volumetric MRI. We describe a voxel-based analysis of nonlinear-registered serial MRI to demonstrate the most statistically significant (P < 0.001) regions of change at different stages of the disease. We compared presymptomatic (n = 4), mild (n = 10), and moderately affected (n = 12) patients with early- and late-onset AD, with age- and sex-matched controls, and demonstrated increasing global atrophy with advancing disease. Significantly increased rates of hippocampal atrophy were seen in presymptomatic and mildly affected patients. There was a shift in the distribution of temporal lobe atrophy with advancing disease; the inferolateral regions of the temporal lobes showed the most significantly increased rates of atrophy by the time the patients were mildly or moderately affected. Significantly increased rates of medial parietal lobe atrophy were seen at all stages, with frontal lobe involvement occurring later in the disease. Our results suggest that the sites showing the most significant rates of atrophy alter as the disease advances, and that regional atrophy is already occurring before the onset of symptoms. This technique provides insights into the natural history of AD, and may be a valuable tool in assessing the efficacy of disease-modifying treatments, especially if these treatments were to have region-specific effects.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Statistical parametric maps for presymptomatic AD (expansion images). In Figs. 1–6, the color overlays show regions of statistically significant (P < 0.001) differences in rates of change compared to controls. The overlays are displayed on an averaged customized MRI template with the same sagittal, coronal and axial sections shown to facilitate comparison across groups.
Figure 2
Figure 2
Statistical parametric maps for mild AD (expansion images). See legend of Fig. 1 for description of color.
Figure 3
Figure 3
Statistical parametric maps for moderate AD (expansion images). See legend of Fig. 1 for description of color.
Figure 4
Figure 4
Statistical parametric maps for presymptomatic AD (contraction images). See legend of Fig. 1 for description of color.
Figure 5
Figure 5
Statistical parametric maps for mild AD (contraction images). See legend of Fig. 1 for description of color.
Figure 6
Figure 6
Statistical parametric maps for moderate AD (contraction images). See legend of Fig. 1 for description of color.

Comment in

References

    1. Braak H, Braak E. Acta Neuropathologica. 1991;82:239–259. - PubMed
    1. Fox N C, Freeborough P A, Rossor M N. Lancet. 1996;348:94–97. - PubMed
    1. Kelly C A, Harvey R J, Cayton H. Br Med J. 1997;314:693–694. - PMC - PubMed
    1. Jack C R, Petersen R C, Xu Y C, Waring S C, O'Brien P C, Tangalos E G, Smith G E, Ivnik R J, Kokmen E. Neurology. 1997;49:786–794. - PMC - PubMed
    1. Lehericy S, Baulac M, Chiras J, Pierot L, Martin N, Pillon B, Deweer B, Dubois B, Marsault C. Am J Neuroradiol. 1994;15:929–937. - PMC - PubMed

Publication types